LOGS - A Randomized Phase II/III study to access the efficacy of Trametinib (GSK 1120212) in patients with recurrent or progressive low-grade serous ovarian cancer or peritoneal cancer (GOG-0281)

Project Details

StatusActive
Effective start/end date21/05/1531/12/21

Funding

  • Other: £44,000.00